Clinical Trials on CLL, Relapsed in United States

Total 169790 results

University of South Florida

Active, not recruiting

Continuous And Data-drivEN CarE (CADENCE) Pilot (CADENCE)

Pregnancy Related | Opioid Use Disorder

United States
PharmaMar

Terminated

Clinical Study of Plitidepsin (Aplidin®) in Combination With Cytarabine in Patients With Relapsed/Refractory Leukemia

Relapsed/Refractory Leukemia

United States
Virginia Commonwealth University
National Institute on Drug Abuse (NIDA)

Terminated

Phase I Functional Magnetic Resonance Imaging (fMRI) Pharmacodynamic Studies of Compounds for Opioid Use Disorder and Cocaine Use Disorder

Opioid-Related Disorders | Cocaine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Fluoxetine to Reduce Cocaine Use in Cocaine and Opioid Addicts

Opioid-Related Disorders | Cocaine-Related Disorders

United States
University of Chicago
National Institute on Drug Abuse (NIDA)

Completed

Effects of Alcohol History on Effects of Nitrous Oxide - 9

Substance-Related Disorders | Alcohol-Related Disorders | Opioid-Related Disorders

United States
University of Chicago
National Institute on Drug Abuse (NIDA)

Completed

Effects of Alcohol History on Effects of Sevoflurane and Nitrous Oxide - 13

Substance-Related Disorders | Alcohol-Related Disorders | Opioid-Related Disorders

United States
Kathleen Ludwig

Available

Expanded Access Program of Venetoclax and Navitoclax for Pediatric Patients With Relapsed or Refractory ALL or LL

Relapsed Childhood ALL | Relapsed Childhood Lymphoblastic Lymphoma

United States
University of Michigan

Completed

Safety and Health Intervention Project (SHIP)

Drug Overdose | Opioid Related Disorders

United States
The University of Texas Health Science Center,...
National Institute on Drug Abuse (NIDA); University of Texas

Terminated

Pharmacotherapy Dosing Regimen in Cocaine and Opiate Dependent Individuals - 8

Opiate Dependence | Cocaine Abuse

United States
National Institute on Drug Abuse (NIDA)
Mclean Hospital

Completed

Treatment Efficacy for Drug Abuse and AIDS Prevention - 1

Heroin Dependence | Cocaine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Texas

Completed

Dextroamphetamine as Adjunct in Cocaine/Opiate Dependent Patients - 3

Opioid-Related Disorders | Cocaine-Related Disorders

United States
University of Vermont
National Institute on Drug Abuse (NIDA)

Completed

Combined Buprenorphine and Behavioral Treatment With and Without Contingent Reinforcement on Opioid and Cocaine Abstinence. - 22

Opioid-Related Disorders | Cocaine-Related Disorders

United States
Indiana University
National Institute on Drug Abuse (NIDA)

Enrolling by invitation

Fatal Overdose Review Teams - Research to Enhance Surveillance Systems (FORTRESS)

Substance-Related Disorders | Opioid-Related Disorders

United States
University of Maryland, Baltimore

Completed

Youth Opioid Recovery Support: Improving Care Systems (YORS)

Opioid-Related Disorders

United States
Roxane Laboratories

Completed

Bioequivalency Study of Buprenorphine Hydrochloride 8 mg Tablet Under Fasted Conditions

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Terminated

Effects of Buprenorphine/Naloxone in Treating Opioid Dependent Individuals Who Are Maintained on Methadone

Opioid-Related Disorders

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Phase IIa Study of AV411, a Glial Activation Inhibitor, for Opioid Withdrawal (AV411)

Opioid-Related Disorders

United States
Boston Children's Hospital

Withdrawn

Computerized Alcohol Screening for Children and Adolescents (cASCA)

Alcohol Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Temporal Discounting Delayed Outcomes on Opioid-Dependent Outpatients - 20

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate-Day Buprenorphine Administration. Phase IV - 5

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate-Day Buprenorphine Administration. Phase VI - 7

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Gradual Vs. Rapid Buprenorphine Detoxification - 2

Opioid-Related Disorders

United States
Potomac Health Foundations

Completed

Youth Opioid Recovery Support: A Developmentally-specific Intervention for Home Delivery of Extended Release Naltrexone (YORS)

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Terminated

Pioglitazone to Treat Opioid Withdrawal Symptoms

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
Johns Hopkins University

Terminated

Abuse Potential of Buprenorphine/Naloxone

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Tramadol to Reduce Opioid Withdrawal Symptoms

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Effects of Buprenorphine/Naloxone Administered in Different Ways For Treating Opioid Dependence

Opioid-Related Disorders

United States
University of Vermont
National Institute on Drug Abuse (NIDA)

Completed

Alternate Day Buprenorphine Administration, Phase XI - 16

Opioid-Related Disorders

United States
University of Vermont
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Dose Alteration Study - 1

Opioid-Related Disorders

United States
University of Vermont
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Detoxification With Two Types of Treatment. BBD III - 12

Opioid-Related Disorders

United States
University of Vermont
National Institute on Drug Abuse (NIDA)

Completed

Alternate Day Buprenorphine Administration, Phase IX - 14

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Buprenorphine Detoxification - BBDVI - 19

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Buprenorphine Detoxification With Two Types of Treatment. BBD IV - 13

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Buprenorphine Pharmacology Related to Addiction Treatment - 18

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate-Day Buprenorphine Administration. Phase I - 3

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate-Day Buprenorphine. Phase V - 6

Opioid-Related Disorders

United States
Chestnut Health Systems

Recruiting

Preventing Parental Opioid and/or Methamphetamine Addiction Within DHS-Involved Families: FAIR (PRE-FAIR)

Opioid-Related Disorders | Mental Health Impairment | Child Neglect | Stimulant-Related Disorder

United States
University of Utah

Completed

Perinatal Care and Medication Assisted Treatment: Carbon/Emery Counties

Pregnancy Related | Opioid-use Disorder

United States
University of Pittsburgh
National Institute on Drug Abuse (NIDA)

Enrolling by invitation

STEPuP: Prenatal Provider Education and Training to Improve Medication-assisted Treatment Use During Pregnancy (STEPuP)

Pregnancy Related | Opioid-use Disorder

United States
Baylor College of Medicine
Cancer Prevention Research Institute of Texas; The Methodist Hospital Research... and other collaborators

Active, not recruiting

C7R-GD2.CART Cells for Patients With Relapsed or Refractory Neuroblastoma and Other GD2 Positive Cancers (GAIL-N)

Refractory Neuroblastoma | Uveal Melanoma | Relapsed Ewing Sarcoma | Relapsed Osteosarcoma | Relapsed Neuroblastoma | Relapsed Rhabdomyosarcoma | Phyllodes Breast Tumor

United States
University of Colorado, Denver
University of Kentucky

Completed

A Study of Eribulin in Combination With Oral Irinotecan for Adolescent and Young Adult Patients With Relapsed or Refractory Solid Tumors

Refractory Solid Tumors | Relapsed Solid Tumors

United States
Baylor College of Medicine
National Institute on Drug Abuse (NIDA); Yale University

Completed

Pharmacogenetics of Disulfiram for Cocaine (Disulfiram)

Opioid Dependence | Cocaine Dependence

United States
National Institute on Drug Abuse (NIDA)
Mclean Hospital

Completed

Treatment Efficacy for Drug Abuse and AIDS Prevention - 2

Heroin Dependence | Cocaine-Related Disorders

United States
University of Pittsburgh
National Institute on Drug Abuse (NIDA)

Completed

Opioid Dependence Treatment Therapies in Pregnancy

Pregnancy | Opioid-Related Disorders

United States
University of Pennsylvania
Yale University

Recruiting

Tau PET Imaging in Opioid Use Disorder

Opioid-Related Disorders

United States
Geisinger Clinic

Completed

Evaluation of a Medication Disposal Program in Primary Care

Opioid-Related Disorders

United States
Johns Hopkins University
National Institute on Drug Abuse (NIDA)

Completed

Fetal Neurobehavioral Development in Methadone Maintained Pregnancies

Opioid-Related Disorders

United States
Johns Hopkins University
National Institute on Drug Abuse (NIDA)

Completed

Improving Learning-based Treatment of Cocaine Dependence With Medication

COCAINE-RELATED DISORDERS

United States
National Institute of Allergy and Infectious Diseases...

Terminated

Assessing Abuse Potential of Parenteral Buprenorphine/Naloxone in Non-Dependent Opioid Abusers

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
Johns Hopkins University

Terminated

Opioid Agonist and Antagonist Effects on Opioid Dependence

Opioid-Related Disorders

United States

Clinical Trials on CLL, Relapsed in United States

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Vietnam

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations